Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC

Published:2023-07 Issue: Volume:181 Page:107258
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Heenatigala Palliyage Gayathri,Samart Parinya,Bobbala Sharan,Rojanasakul Liying W.,Coyle Jayme,Martin Karen,Callery Patrick S.,Rojanasakul Yon

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference48 articles.

1. Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth;Takahashi;Oncotarget.,2015

2. Causes of death in long-term survivors of non-small cell lung cancer: A regional Surveillance, Epidemiology, and End Results study;Kanitkar;Ann. Thorac. Med.,2018

3. Hong Y, Park S, Lee MK. The prognosis of non-small cell lung cancer patients according to endobronchial metastatic lesion. Sci Rep. Aug 10 2022;12(1):13588. doi:10.1038/s41598-022-17918-1.

4. Changes in morphologic and biochemical characteristics of small cell carcinoma of the lung. A clinicopathologic study;Abeloff;Am. J. Med.,1979

5. Drug resistance and combating drug resistance in cancer;Wang;Cancer Drug Resist.,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durvalumab and taxane family combination therapy enhances the antitumoral effects for NSCLC: An in vitro study;Cell Biochemistry and Function;2024-01

2. Pembrolizumab plus chemotherapy per PD-L1 stratum in patients with metastatic non-small cell lung cancer: real-world effectiveness versus trial efficacy;Clinical Lung Cancer;2023-12

3. Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome;Cancer Immunology, Immunotherapy;2023-11-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3